Mylan has launched a lawsuit against Cipla for allegedly copying the get-up of its blockbuster cholesterol drug Lipidil, after losing a bid to block Cipla and Sun Pharma from selling generic versions of the drug while it appeals a ruling invalidating several claims of its patents.
Patents at the centre of a high stakes IP dispute between tech giants Motorola and Hytera have significantly more than the necessary “scintilla of inventiveness” to be deemed valid, Motorola said on the first day of a month-long trial.
A unit of Boehringer Ingelheim has been given more time to oppose a proposed patent by rival drug maker Intervet, after the German drug company’s lawyers sent an email with the wrong opposition deadline.
Blue Sky Alternative Investments has reached a confidential settlement of its case against three former directors and two investment firms over an alleged raid on the fund manager’s confidential database.
Apple has been granted a patent for an animation-generating user interface for its iPhone and iPad devices, beating back multiple adverse examination reports that described the invention as a presentation of “aesthetic content” that solved the problem “providing users with something engaging to look at”.
The overwhelming majority of employees at small and medium-sized law firms are being affected by depression and anxiety, with a new survey revealing almost one in three work more than 45 hours a week.
NSW Ports Operations has denied claims that an agreement for the privatisation of its subsidiaries Port Botany and Port Kembla stymied competition, describing the allegations made by the Australian Competition and Consumer Commission as “slight or hypothetical”.
Lawyers for media outlet Buzzfeed say they are “very close” to settling a defamation case brought by former Labor MP Emma Husar, over an article that accused her of sexual harassment and exposing herself in a manner made famous by Sharon Stone in the movie Basic Instinct.
Group members in a recently settled class action against Westpac unit BankSA over its conduct in connection with convicted Ponzi schemer Michael Samra are expected to get 40 per cent of the confidential settlement, a result a judge said wasn’t as bad as he might have feared.
The jailed former CEO of defunct health food business Healthzone has lost his appeal of a criminal conviction and sentence over a conspiracy to fraudulently use a $1 million company bank loan to repay personal debts.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
